These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24335483)

  • 21. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
    Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
    J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.
    Palmer CS; Duette GA; Wagner MCE; Henstridge DC; Saleh S; Pereira C; Zhou J; Simar D; Lewin SR; Ostrowski M; McCune JM; Crowe SM
    FEBS Lett; 2017 Oct; 591(20):3319-3332. PubMed ID: 28892135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians.
    Kassu A; Tsegaye A; Wolday D; Petros B; Aklilu M; Sanders EJ; Fontanet AL; Van Baarle D; Hamann D; De Wit TF
    Clin Exp Immunol; 2003 Apr; 132(1):113-9. PubMed ID: 12653845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.
    Kalayjian RC; Spritzler J; Matining RM; Fiscus SA; Gross BH; Francis IR; Pollard RB; Lederman MM; Landay A
    AIDS; 2013 Jun; 27(10):1563-71. PubMed ID: 24047762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.
    Gougeon ML; Lecoeur H; Dulioust A; Enouf MG; Crouvoiser M; Goujard C; Debord T; Montagnier L
    J Immunol; 1996 May; 156(9):3509-20. PubMed ID: 8617980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
    J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.
    Zhuang Y; Wei X; Li Y; Zhao K; Zhang J; Kang W; Sun Y
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1044-51. PubMed ID: 22214236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
    Tincati C; Bellistrì GM; Ancona G; Merlini E; d'Arminio Monforte A; Marchetti G
    Clin Dev Immunol; 2012; 2012():935425. PubMed ID: 22400042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients.
    Ramzaoui S; Jouen-Beades F; Michot F; Borsa-Lebas F; Humbert G; Tron F
    Clin Exp Immunol; 1995 Feb; 99(2):182-8. PubMed ID: 7851009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    Meng Q; Sayin I; Canaday DH; Mayanja-Kizza H; Baseke J; Toossi Z
    PLoS One; 2016; 11(11):e0166954. PubMed ID: 27870882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.
    Kavanagh Williamson M; Coombes N; Juszczak F; Athanasopoulos M; Khan MB; Eykyn TR; Srenathan U; Taams LS; Dias Zeidler J; Da Poian AT; Huthoff H
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29518929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.
    Karim R; Mack WJ; Stiller T; Operskalski E; Frederick T; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Kovacs A
    AIDS; 2013 Jun; 27(9):1473-81. PubMed ID: 23945505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation.
    Wittner M; Dunay GA; Kummer S; Bockhorn M; Hüfner A; Schmiedel S; Degen O; van Lunzen J; Eberhard JM; Schulze Zur Wiesch J
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):345-349. PubMed ID: 29293157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.